← FDA Drug Approvals (Drugs@FDA)
CABAZITAXEL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2023-02-10
Drug application
- FDA Application #
ANDA207736- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CABAZITAXEL
- Generic name
- Cabazitaxel
- Active ingredients
- CABAZITAXEL
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- APOTEX
- First approval
- 2023-02-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown